Juan Toro Barahona
About Juan Toro Barahona
Juan Toro Barahona is a Senior Medical Manager at Kite Pharma with extensive experience in managing CAR-T cell therapies for hematological conditions. He has worked in various capacities in the pharmaceutical industry and healthcare settings, focusing on innovative treatments for lymphomas and leukemias.
Work at Kite Pharma
Juan Toro Barahona has been serving as a Senior Medical Manager at Kite Pharma since 2019. In this role, he focuses on the management and development of CAR-T cell therapies for hematological conditions. His work involves overseeing innovative treatment strategies and ensuring the effective application of these therapies in clinical settings. Kite Pharma is known for its commitment to advancing cell therapy, and Juan's expertise contributes to the company's mission in this area.
Previous Experience at Janssen Pharmaceutical
Prior to his current position, Juan worked at The Janssen Pharmaceutical Companies of Johnson & Johnson in various roles. He served as a Senior Medical Science Liaison from 2017 to 2018 and as a Medical Affairs Manager from 2018 to 2019. During his time at Janssen, he gained valuable experience in managing therapies for hematological conditions, particularly focusing on CAR-T cell therapies. His work in Madrid y alrededores, España, involved collaboration with healthcare professionals to enhance treatment outcomes.
Education and Expertise
Juan holds a Licenciatura en Medicina from Universidad de Extremadura, completed between 2005 and 2011. He furthered his education by studying at Universitat de València, where he achieved a Diploma de Especialización en terapias CAR-T para farmacéuticos hospitalarios y hematólogos in 2021. His studies focused on CAR-T therapies and hematology, equipping him with the knowledge necessary for his specialization in cellular therapy and the treatment of complex lymphomas and leukemias.
Background in Hematology
Juan has a background in hematology that includes a significant role at the NHS, where he worked in the Teenagers and Young Adults Unit (TYA) at Addenbrooke's University Hospital for 11 months in 2017. This experience provided him with insights into the challenges faced by young patients with hematological conditions. His extensive experience in managing therapies for conditions such as Mantle Cell Lymphoma and Acute Lymphoblastic Leukemia underscores his commitment to advancing treatment options in this field.
Focus on Innovative Treatments
Juan Toro Barahona has a strong focus on innovative treatments in hematology, particularly the application of CAR-T cell therapies. He has been involved in the development and management of these therapies for various types of lymphoma, including primary mediastinal B-cell lymphoma and follicular lymphoma. His expertise in this area is critical for addressing complex cases and improving patient outcomes through advanced therapeutic strategies.